@SullivanProf

Cancer, Conflict and Global Health

 United Kingdom
Joined May 2015
  • Tweets1.4K
  • Following429
  • Followers3K
135Media
Include

Only show posts containing:

Exclude

Hide posts containing:

Time range
-
Minimum likes
Further work on Syria and r4hsss.org program - stregthening cancer systems in post conflict Syria frontiersin.org/journals/can…
1
146
Richard Sullivan retweeted
The Lancet Oncology@TheLancetOncolJun 1
An engaging #ASCO26 session: A Workforce Crisis—A Lancet Oncology Commission Authors @hedvighricak, @QUBCancerProf, @SullivanProf, @sudhasdc, @m_mutebi, @Dra_CVillarreal, @WilNgwa + Missed the session? 📽️ Watch: youtu.be/VYr2Bjmxyhg & 📖 Read: thelancet.com/commissions-do…
8
1
16
6,725
A final word on GRAiL in JAMA - promise, hype and reality - academia.edu/167998188/Multi… @ASCO @myESMO
2
4
619
Richard Sullivan retweeted
OncoDaily
@oncodailyMay 7
Addressing the “Intellectual Wastelands” of Global Cancer Policy - Richard Sullivan @SullivanProf oncodaily.com/voices/richard… #OncoDaily #Oncology #Cancer #Health #Medicine #MedX #MedTwitter
1
4
162
Richard Sullivan retweeted
J. Mac Skelton@mac_skeltonMay 5
While civilian injuries in the the Middle East have been widely documented, little is known about civilian trauma pathways. Read our latest in @GlobalHealthBMJ with @GhassanAbuSitt1, @abdulsaterz, @SullivanProf, @gmbowsher, @thewarspace among others. gh.bmj.com/content/11/5/e021…
15
30
3,653
Complexities of rebuilding breast cancer care in post-conflict Syria. Critical lessons for the wider world. academia.edu/166153347/Rebui… @R4HSSS @r4hcmena @BreastDocUK @BCCare @SusanGKomen

Rebuilding Equitable Breast Cancer Care in Post-Conflict Syria

Purpose of the Review Breast cancer is the most common malignancy among Syrian women, yet the country's prolonged conflict has severely disrupted oncology services. Our aim is to explore, through...

academia.edu
1
3
166
Brilliant. And absolutely spot on. blogs.bmj.com/bmj/2015/12/11… @RCSEd @IGSS_InciSioN @QueensGlobalOnc

Jonathan Glass: If surgeons lived Lewis Hamilton’s life - The BMJ

Many of the medical conferences I have attended recently have included sessions suggesting that the NHS is failing in its processes and that there is lots we can learn from [...]More...

blogs.bmj.com
1
168
Richard Sullivan retweeted
Aju Mathew@ajumathew_Apr 7
Quite simply, a brilliantly written review on Chinese Pharma - From 2015 to 2024, over 393 cancer medicines were approved worldwide, 72 were China's branded new medicines. eg; zanubrut, tisleliz, avaprit, toripali, fruquin. @SullivanProf @kjmeetswrld ascopubs.org/doi/10.1200/GO-…

China's Growing Importance in Global Cancer Medicines | JCO Global Oncology

Following the global shift toward innovation-driven cancer care, China has rapidly transformed its cancer medicine research, development, regulation, and financing systems over the past decade. This...

ascopubs.org
12
1
37
3,780
Richard Sullivan retweeted
J. Mac Skelton@mac_skeltonMar 9
What are the immediate and long-term implications of war for cancer care? Our editorial in @bmjoncology explores this question through lessons from Ukraine. With @gmbowsher, @SullivanProf, and Kateryna Denysenko: bmjoncology.bmj.com/content/…
1
5
13
783
Richard Sullivan retweeted
Kristina Jenei@kjmeetswrldMar 6
Our new article about @WHO essential cancer medicines published today in JAMA Oncology with @SullivanProf We ask: how to implement these medicines? jamanetwork.com/journals/jam…
1
9
319
Final report from cancer conference organised by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, held in Vatican City in 2025 pubmed.ncbi.nlm.nih.gov/4139…
4
215
Disparity in affordability across targeted and Immune-therapy cancer medicines used in the treatment of Head and Neck cancer doi.org/10.1002/hed.70212
3
217
Huge gaps in our understanding of cancer care in refugee and asylum populations. academia.edu/164818349/Cance… @QF @WHO

Cancer Control in Refugee and Asylum Seeker Populations: A Scoping Review

PURPOSE Displaced individuals face significant health care access challenges, particularly for noncommunicable diseases. For these individuals, cancer control remains a severely neglected aspect of...

academia.edu
1
3
332
Richard Sullivan retweeted
Kristina Jenei@kjmeetswrldJan 30
New Correspondence in @TheLancet Cancer medicines remain absent from global access metrics. #accesstomedicines #globaloncology @SullivanProf @LSEHealthPolicy @KingsCollegeLon
3
13
819
Report from the Pontifical Academy of Sciences & European Academy of Cancer Sciences meeting held in Vatican City. A complex picture of innovation, global inequity & increasing divergence between science & systems implementation. pubmed.ncbi.nlm.nih.gov/4139… @WHO @EU_Commission

Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention,...

The cancer problem is expanding, particularly in low- and middle-income countries (LMICs). Preventive measures can reduce the incidence by 40-50%, and cure rates have increased during the past...

pubmed.ncbi.nlm.nih.gov
1
1
274
The stark realities of healthcare for displaced people. As conflict's worsen so too does the problem. Yet we are seeing societal attitudes worsen and protection increasingly eroded. thelancet.com/journals/lance…
1
1
2
187
Important work by @DavidiTawfiles & our team in @TheLancet: "#Health #equity and displaced people: challenges, progress, and the path forward." 🌍🌎🌏This #InternationalMigrantsDay, heath of those most vulnerable should be a global priority 🔗 thelancet.com/journals/lance…
Davidi Tawfiles@DavidiTawfiles17 Dec 2025
With #InternationalMigrantDay tomorrow, I’m honored to share our latest in @TheLancet “Health equity and displaced people: challenges, progress, and the path forward.” thelancet.com/journals/lance… Grateful to our team for their insight and commitment to the health of displaced.
1
4
8
973
Global health, security and war and cancer across SSA. wiley.com/en-us/Handbook+of+…
3
194
New insights from Access Cancer Care India program (accesscancercare.in/) - the poverty of national cancer plan implimentation. See doi:10.1136/ bmjopen-2025-10875 @WHO
2
137
Op ed led by Dr Steven Bradley examining how a new England National Cancer Plan could and should embrace wider vision of innovation doi.org/10.1136/bmj.r2263
1
121
Load more